Author:
Stanfield Zachary,Coşkun Mustafa,Koyutürk Mehmet
Abstract
Abstract
Drug response prediction is a well-studied problem in which the molecular profile of a given sample is used to predict the effect of a given drug on that sample. Effective solutions to this problem hold the key for precision medicine. In cancer research, genomic data from cell lines are often utilized as features to develop machine learning models predictive of drug response. Molecular networks provide a functional context for the integration of genomic features, thereby resulting in robust and reproducible predictive models. However, inclusion of network data increases dimensionality and poses additional challenges for common machine learning tasks. To overcome these challenges, we here formulate drug response prediction as a link prediction problem. For this purpose, we represent drug response data for a large cohort of cell lines as a heterogeneous network. Using this network, we compute “network profiles” for cell lines and drugs. We then use the associations between these profiles to predict links between drugs and cell lines. Through leave-one-out cross validation and cross-classification on independent datasets, we show that this approach leads to accurate and reproducible classification of sensitive and resistant cell line-drug pairs, with 85% accuracy. We also examine the biological relevance of the network profiles.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Meyerson, M., Gabriel, S. & Getz, G. Advances in understanding cancer genomes through second-generation sequencing. Nature Publishing Group 11, 685–696 (2010).
2. Buermans, H. P. J. & den Dunnen, J. T. Next generation sequencing technology : Advances and applications. Biochimica et Biophysica Acta 1842, 1932–1941 (2014).
3. Varghese, A. M. & Berger, M. F. Advancing clinical oncology through genome biology and technology. Genome Biology 15, 1–7 (2014).
4. Chen, R. & Snyder, M. Promise of Personalized Omics to Precision Medicine. Wiley Interdiscip Rev Syst Biol Med 5, 73–82 (2013).
5. Yang, W. et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic acids research 41, D955–61 (2013).
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献